Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Institute of Brain Activation is a Japan-based healthcare technology company focused on cognitive assessment, dementia prevention, and brain health monitoring. The company commercializes "Brain Assessment" (脳検), a cognitive function testing service designed to measure memory, spatial recognition, and related brain performance indicators across adults, including home-based and institutional use cases. Its offerings appear to span online cognitive testing, enterprise and research deployment, brain-health related monitoring programs, and simple point-of-care wellness check devices such as an AI smile measurement tool. The company also supports use of its assessment tools in hospitals, pharmacies, fitness settings, corporate health programs, academic research, and clinical study support. Overall, it is best characterized as a digital health and preventive brain-health company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Institute of Brain Activation.